Scheeringa MS, Zeanah CH, Cohen JA. PTSD in children and adolescents: toward an empirically based algorithma. Depress Anxiety. 2011;28:770–82.
Article
PubMed
Google Scholar
Kovachy B, O’Hara R, Hawkins N, Gershon A, Primeau MM, Madej J, et al. Sleep disturbance in pediatric PTSD: current findings and future directions. J Clin Sleep Med. 2013;9:501–10.
PubMed
PubMed Central
Google Scholar
Keeshin BR, Strawn JR. Psychological and pharmacologic treatment of youth with posttraumatic stress disorder: an evidence-based review. Child Adolesc Psychiatr Clin N Am. 2014;23:399–411.
Article
PubMed
Google Scholar
Morina N, Koerssen R, Pollet TV. Interventions for children and adolescents with posttraumatic stress disorder: a meta-analysis of comparative outcome studies. Clin Psychol Rev. 2016;47:41–54.
Article
PubMed
Google Scholar
Silverman WK, Ortiz CD, Viswesvaran C, Burns BJ, Kolko DJ, Putnam FW, et al. Evidence-based psychosocial treatments for children and adolescents exposed to traumatic events. J Clin Child Adolesc Psychol. 2008;37:156–83.
Article
PubMed
Google Scholar
Cohen JA, Mannarino AP, Perel JM, Staron V. A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. J Am Acad Child Adolesc Psychiatry. 2007;46:811–9.
Article
PubMed
Google Scholar
Robb AS, Cueva JE, Sporn J, Yang R, Vanderburg DG. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2010;20:463–71.
Article
PubMed
Google Scholar
Strawn JR, Keeshin BR. Successful treatment of posttraumatic stress disorder with prazosin in a young child. Ann Pharmacother. 2011;45:1590–1.
Article
PubMed
Google Scholar
Strawn JR, Delbello MP, Geracioti TD. Prazosin treatment of an adolescent with posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2009;19:599–600.
Article
PubMed
Google Scholar
Brkanac Z, Pastor JF, Storck M. Prazosin in PTSD. J Am Acad Child Adolesc Psychiatry. 2003;42:384–5
Article
PubMed
Google Scholar
Connor DF, Grasso DJ, Slivinsky MD, Pearson GS, Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol. 2013;23:244–51.
CAS
Article
PubMed
PubMed Central
Google Scholar
Strawn JR, Geracioti TD. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety. 2008;25:260–71.
CAS
Article
PubMed
Google Scholar
Germain A, Buysse DJ, Nofzinger E. Sleep-specific mechanisms underlying posttraumatic stress disorder: integrative review and neurobiological hypotheses. Sleep Med Rev. 2008;12:185–95.
Article
PubMed
Google Scholar
Harvey AG, Jones C, Schmidt DA. Sleep and posttraumatic stress disorder: a review. Clin Psychol Rev. 2003;23:377–407.
Article
PubMed
Google Scholar
Geracioti TD, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry. 2001;158:1227–30.
Article
PubMed
Google Scholar
De Bellis MD, Lefter L, Trickett PK, Putnam FW. Urinary catecholamine excretion in sexually abused girls. J Am Acad Child Adolesc Psychiatry. 1994;33:320–7.
Article
PubMed
Google Scholar
De Bellis MD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM, et al. A. E. Bennett Research Award. Developmental traumatology. Part I: biological stress systems. Biol Psychiatry. 1999;45:1259–70.
Article
PubMed
Google Scholar
Pervanidou P, Chrousos GP. Post-traumatic Stress Disorder in children and adolescents: from Sigmund Freud’s ‘trauma’ to psychopathology and the (Dys)metabolic syndrome. Horm Metab Res. 2007;39:413–9.
CAS
Article
PubMed
Google Scholar
Keeshin BR, Strawn JR, Out D, Granger DA, Putnam FW. Elevated salivary alpha amylase in adolescent sexual abuse survivors with posttraumatic stress disorder symptoms. J Child Adolesc Psychopharmacol. 2015;25:344–50.
CAS
Article
PubMed
PubMed Central
Google Scholar
Famularo R, Kinscherff R, Fenton T. Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. Am J Dis Child. 1988;142:1244–7.
CAS
Article
PubMed
Google Scholar
Nugent NR, Christopher NC, Crow JP, Browne L, Ostrowski S, Delahanty DL. The efficacy of early propranolol administration at reducing PTSD symptoms in pediatric injury patients: a pilot study. J Trauma Stress. 2010;23:282–7.
PubMed
PubMed Central
Google Scholar
Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009;48:884–93.
Article
PubMed
PubMed Central
Google Scholar
Donnelly CL. Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder. Child Adolesc Psychiatr Clin N Am. 2003;12:251–69.
Article
PubMed
Google Scholar
Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996;35:1247–9.
CAS
Article
PubMed
Google Scholar
Porter DM, Bell CC. The use of clonidine in post-traumatic stress disorder. J Natl Med Assoc. 1999;91:475–7.
CAS
PubMed
PubMed Central
Google Scholar
Horrigan JP, Barnhill LJ. The suppression of nightmares with guanfacine. J Clin Psychiatry. 1996;57:371.
CAS
PubMed
Google Scholar
Sallee FR, Lyne A, Wigal T, McGough JJ. Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19:215–26.
Article
PubMed
Google Scholar
Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61:928–34.
CAS
Article
PubMed
Google Scholar
Raskind MA, Thompson C, Petrie EC, Dobie DJ, Rein RJ, Hoff DJ, et al. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry. 2002;63:565–8.
CAS
Article
PubMed
Google Scholar
Byers MG, Allison KM, Wendel CS, Lee JK. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety. J Clin Psychopharmacol. 2010;30:225–9.
Article
PubMed
Google Scholar
Raskind MA, Peskind ER, Kanter ED, Petrie EC, Radant A, Thompson CE, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003;160:371–3.
Article
PubMed
Google Scholar
Boynton L, Bentley J, Strachan E, Barbato A, Raskind M. Preliminary findings concerning the use of prazosin for the treatment of posttraumatic nightmares in a refugee population. J Psychiatr Pract. 2009;15:454–9.
Article
PubMed
Google Scholar
George KC, Kebejian L, Ruth LJ, Miller CWT, Himelhoch S. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. J Trauma Dissociation. 2016;17:494–510.
Article
PubMed
Google Scholar
Menkes DB, Baraban JM, Aghajanian GK. Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain. Naunyn Schmied Arch Pharmacol. 1981;317:273–5.
CAS
Article
Google Scholar
Strawn JR, Keeshin BR, Delbello MP, Geracioti TD, Putnam FW. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J Clin Psychiatry. 2010;71:932–41.
CAS
Article
PubMed
Google Scholar
Hasford J, Bussmann WD, Delius W, Koepcke W, Lehmann K, Weber E. First dose hypotension with enalapril and prazosin in congestive heart failure. Int J Cardiol. 1991;31:287–93.
CAS
Article
PubMed
Google Scholar
Pynoos RS, Steinberg AM. UCLA PTSD Reaction Index: DSM-5 Version. Los Angeles, CA, USA: National Center for Child Traumatic Stress; 2014
Google Scholar
Armstrong JG, Putnam FW, Carlson EB, Libero DZ, Smith SR. Development and validation of a measure of adolescent dissociation: the adolescent dissociative experiences scale. J Nerv Ment Dis. 1997;185:491–7.
CAS
Article
PubMed
Google Scholar
Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976. pp. 76–338
Google Scholar
Steinberg AM, Brymer MJ, Kim S, Briggs EC, Ippen CG, Ostrowski SA, et al. Psychometric properties of the UCLA PTSD reaction index: part I. J Trauma Stress. 2013;26:1–9.
Article
PubMed
Google Scholar
Elhai JD, Layne CM, Steinberg AM, Brymer MJ, Briggs EC, Ostrowski SA, et al. Psychometric properties of the UCLA PTSD reaction index. Part II: investigating factor structure findings in a national clinic-referred youth sample. J Trauma Stress. 2013;26:10–8.
Article
PubMed
Google Scholar
Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573–83.
Article
PubMed
Google Scholar
Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, et al. The screen for child anxiety related emotional disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36:545–53.
CAS
Article
PubMed
Google Scholar
Moore N, Fresel J, Joannidès R, Compagnon P, Thuillez C. A comparison of the hemodynamic effects of urapidil, prazosin, and clonidine in healthy volunteers. Blood Press Suppl. 1994;4:7–12.
CAS
PubMed
Google Scholar
Reid JL, Campbell BC, Hamilton CA. Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. Hypertension. 1984;6:II71–5.
CAS
Article
PubMed
Google Scholar
Campbell BC, Reid JL. Regimen for the control of blood pressure and symptoms during clonidine withdrawal. Int J Clin Pharmacol Res. 1985;5:215–22.
CAS
PubMed
Google Scholar
Kung S, Espinel Z, Lapid MI. Treatment of nightmares with Prazosin: a systematic review. Mayo Clin Proc. 2012;87:890–900.
CAS
Article
PubMed
PubMed Central
Google Scholar
Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr. 2008;13:1047–55.
CAS
Article
PubMed
Google Scholar
Hirota T, Schwartz S, Correll CU. Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. J Am Acad Child Adolesc Psychiatry. 2014;53:153–73.
Article
PubMed
Google Scholar